Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Human stem cells can aid stroke recovery, research experiences boost students' career aspirations, minoxidil may reduce cancer spread, a molecule can slow tumor growth, a protein affects water flow in cells, magnesium behaves differently at tiny scales, and a new method detects slow-moving objects.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

Methotrexate's effectiveness for maintaining hair regrowth in alopecia totalis is unclear due to limited and biased data.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Adding a second method to PROTACs could improve cancer treatment.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Metabolic syndrome may increase the risk of small cell lung cancer.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.